Earnings Call Summary | So-young International(SY.US) Q1 2024 Earnings Conference
Earnings Call Summary | So-young International(SY.US) Q1 2024 Earnings Conference
The following is a summary of the So-Young International Inc. (SY) Q1 2024 Earnings Call Transcript:
以下是素阳国际公司（SY）2024年第一季度财报电话会议记录摘要：
Financial Performance:
财务业绩：
So-Young reported Q1 total revenues of RMB318.3 million, achieving non-GAAP profitability for the quarter.
Revenue from sales of medical products and maternity services increased by 23.3% YoY, with a net loss attributable to So-Young of RMB 21.2 million.
The company maintained a strong cash position, with assets totaling RMB 1.3 billion as of March 31, 2024.
苏阳公布的第一季度总收入为人民币3.183亿元，实现了该季度的非公认会计准则盈利能力。
医疗产品和孕产服务的销售收入同比增长23.3％，归属于素阳的净亏损为2,120万元人民币。
该公司保持强劲的现金状况，截至2024年3月31日，资产总额为13亿元人民币。
Business Progress:
业务进展：
So-Young experienced rapid growth in new businesses and diversification of upstream product offerings.
The company made significant progress in clinic chain expansions with three new clinics in Q1 and projects a scale of 100 to 150 clinics in the next three years.
Sales of upstream medical aesthetic products increased by 80% YoY and a distribution network established across 715 institutions. For Q2 2024, projected total revenues between RMB 380 million and RMB 400 million.
So-Young 经历了新业务的快速增长和上游产品供应的多元化。
该公司在诊所连锁扩张方面取得了重大进展，第一季度新增了三家诊所，并预计未来三年将扩大到100至150家诊所。
上游医疗美容产品的销售额同比增长了80％，分销网络遍及715家机构。2024年第二季度，预计总收入在3.8亿元人民币至4亿元人民币之间。
More details: So-young International IR
更多详情： 素英国际投资者关系
Tips: This article is generated by AI. The accuracy of the content can not be fully guaranteed. For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：本文由 AI 生成。无法完全保证内容的准确性。欲了解更多详情，请访问投资者关系网站。本文仅供投资者参考，不构成任何投资建议。